These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8147983)

  • 21. International conference on harmonisation; guidance on statistical principles for clinical trials; availability--FDA. Notice.
    Fed Regist; 1998 Sep; 63(179):49583-98. PubMed ID: 10185190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Participation of women in clinical trials of drug therapies: a context for the controversies.
    Prout MN; Fish SS
    Medscape Womens Health; 2001 Oct; 6(5):1. PubMed ID: 11698923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major medical journals will require registration of clinical trials for publication.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Oct; 15(19):1-2, 6-7. PubMed ID: 15473047
    [No Abstract]   [Full Text] [Related]  

  • 24. News from the Society for Women's Health Research: subgroup analysis in clinical trials: detecting sex differences.
    Greenberger PE; Knab S
    J Womens Health Gend Based Med; 2002; 11(1):7-9. PubMed ID: 11860718
    [No Abstract]   [Full Text] [Related]  

  • 25. Ethics. Clinical trials guidelines at odds with U.S. policy.
    Normile D
    Science; 2008 Oct; 322(5901):516. PubMed ID: 18948510
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA issues guidance on race and ethnicity data.
    Meadows M
    FDA Consum; 2003; 37(3):36. PubMed ID: 12793392
    [No Abstract]   [Full Text] [Related]  

  • 27. Females in clinical studies: where are we going?
    Uhl K; Parekh A; Kweder S
    Clin Pharmacol Ther; 2007 Apr; 81(4):600-2. PubMed ID: 17314925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethical problems arise over clinical trials on new drugs.
    Hosp Ethics; 1992; 8(5):12-3. PubMed ID: 10120132
    [No Abstract]   [Full Text] [Related]  

  • 29. Good clinical practice in clinical drug trials--what you need to know.
    Soyebi K; Abosede ; Coker HA; Osuntoki ; Oyibos W; Keri H; Ogunsola S
    Nig Q J Hosp Med; 2008; 18(2):104-12. PubMed ID: 19068563
    [No Abstract]   [Full Text] [Related]  

  • 30. Women in clinical trials of new drugs. A change in Food and Drug Administration policy. The Working Group on Women in Clinical Trials.
    Merkatz RB; Temple R; Subel S; Feiden K; Kessler DA
    N Engl J Med; 1993 Jul; 329(4):292-6. PubMed ID: 8305004
    [No Abstract]   [Full Text] [Related]  

  • 31. They are from the government and they really are here to help you.
    Woosley RL
    J Clin Pharmacol; 2008 Feb; 48(2):142-3. PubMed ID: 18199889
    [No Abstract]   [Full Text] [Related]  

  • 32. Cautious welcome for FDA pharmacogenomics guidance.
    Katsnelson A;
    Nat Biotechnol; 2005 May; 23(5):510. PubMed ID: 15877053
    [No Abstract]   [Full Text] [Related]  

  • 33. Investigational new drug, antibiotic, and biological product applications; clinical hold and termination--FDA. Final rule.
    Fed Regist; 1992 Apr; 57(73):13244-9. PubMed ID: 10118458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(202):61134-5. PubMed ID: 16237860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trials end at gene-therapy institute..
    Smaglik P
    Nature; 2000 Jun; 405(6786):497. PubMed ID: 10850679
    [No Abstract]   [Full Text] [Related]  

  • 36. International Conference on Harmonisation; guidance on data elements for transmission of individual case safety reports; availability. Notice. Food and Drug Administration, HHS.
    Fed Regist; 1998 Jan; 63(10):2396-404. PubMed ID: 12296373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International Conference on Harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2000 Dec; 65(242):78493-4. PubMed ID: 12362934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Communicating with the FDA: the "third rail" of a new model for drug development.
    Stanski DR; Orloff JJ
    J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
    [No Abstract]   [Full Text] [Related]  

  • 39. Critique of the Guidelines for Clinical Evaluation of Antianxiety Drugs (HEW-FDA-77-3043).
    Cohn JB; Gottschalk LA
    Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):313-5. PubMed ID: 45206
    [No Abstract]   [Full Text] [Related]  

  • 40. Guidelines for the clinical evaluation of antianxiety drugs. HEW (FDA) 77-3043, September 1977.
    Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):297-312. PubMed ID: 45205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.